Pages that link to "Item:Q263587"
From MaRDI portal
The following pages link to Optimal control in a model of dendritic cell transfection cancer immunotherapy (Q263587):
Displaying 41 items.
- A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy (Q309128) (← links)
- Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule (Q376458) (← links)
- Mathematical models for immunology: current state of the art and future research directions (Q518216) (← links)
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
- New developments in the application of optimal control theory to therapeutic protocols (Q905822) (← links)
- On optimal delivery of combination therapy for tumors (Q1042733) (← links)
- Optimal control applied to immunotherapy (Q1430351) (← links)
- Dendritic immunotherapy improvement for an optimal control murine model (Q1664521) (← links)
- An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol (Q1680709) (← links)
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer (Q1712868) (← links)
- A new conceptual framework for the therapy by optimized multidimensional pulses of therapeutic activity. The case of multiple myeloma model (Q1714202) (← links)
- A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy (Q1758078) (← links)
- Optimization of combination therapy for chronic myeloid leukemia with dosing constraints (Q1789085) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- Controlling IL-7 injections in HIV-infected patients (Q1990146) (← links)
- Spatial avascular growth of tumor in a homogeneous environment (Q2013437) (← links)
- Analysis of stochastic dynamics of tumor with drug interventions (Q2098727) (← links)
- Optimal control with isoperimetric constraint for chemotherapy of tumors (Q2170964) (← links)
- Mathematical modelling of cancer stem cell-targeted immunotherapy (Q2173873) (← links)
- Optimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approach (Q2189975) (← links)
- Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison (Q2192671) (← links)
- Cancer immunotherapy, mathematical modeling and optimal control (Q2219776) (← links)
- Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model (Q2223666) (← links)
- Modelling pulsed immunotherapy of tumour-immune interaction (Q2228589) (← links)
- Equilibria and control of metabolic networks with enhancers and inhibitors (Q2305096) (← links)
- A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer (Q2413866) (← links)
- A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity (Q2415802) (← links)
- Determination of the optimal therapeutic protocols in cancer immunotherapy (Q2455540) (← links)
- Periodically pulsed immunotherapy in a mathematical model of tumor-immune interaction (Q2845197) (← links)
- A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS (Q2977597) (← links)
- MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS (Q3390818) (← links)
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS (Q3530573) (← links)
- Tumor Control, Elimination, and Escape through a Compartmental Model of Dendritic Cell Therapy for Melanoma (Q5107198) (← links)
- A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST (Q5120283) (← links)
- A tumor-Immune interaction model with the effect of impulse therapy (Q6058689) (← links)
- On the optimal control problem for a model of the synergy of chemo‐ and immunotherapy (Q6125652) (← links)
- A model of tumor‐immune system interactions with healthy cells and immunotherapies (Q6139688) (← links)
- Bang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancer (Q6154515) (← links)
- OPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITY (Q6173429) (← links)
- Adaptive protocols based on predictions from a mechanistic model of the effect of IL7 on CD4 counts (Q6625544) (← links)
- Chemo and immunotherapy effects on stability regions of tumor models (Q6659307) (← links)